4 active not recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 4 |
Follow NHL: new trials by email Literature Review of NHL trials Research Report on NHL
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Point-of-care Produced CAR T-cell With Commercial CAR T-cells in Patients With R/R LBCL ARI-0001, Axi-cel - NHL, DLBCL - Diffuse Large B Cell Lymphoma | Phase 2 | Active not recruiting | University Medical Center Groningen | 340 | 2022-10-18 | 2026-10-05 |
| Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma Rituximab, Copanlisib, Bone Marrow Aspiration/Biopsy - Follicular Lymphoma, Non-Hodgkin's Lymphoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 33 | 2019-08-22 | 2026-03-03 |
| A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant Hyperbaric oxygen - AML, NHL | Phase 2 | Active not recruiting | University of Rochester | 64 | 2019-02-28 | 2026-07-20 |
| The Feasibility and Clinical Efficacy of Atezolizumab Consolidation Treatment in High Risk (IPI > 2) DLBCL Atezolizumab - NHL, DLBCL | Phase 2 | Active not recruiting | Stichting Hemato-Oncologie voor Volwassenen Nederland | 109 | 2018-08-30 | 2026-09-23 |
Dendritic Cell Sarcoma, Interdigitating (1) · Hodgkin Disease (1) · Lymphoma, Follicular (1) · Lymphoma, Non-Hodgkin (1) · Myelodysplastic Syndromes (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hemic and Lymphatic Diseases (3) · Lymphatic Diseases (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphoma (2) · Lymphoproliferative Disorders (2) · Bone Marrow Diseases (1) · Hematologic Diseases (1) · Histiocytic Disorders, Malignant (1) · Histiocytosis (1) · Leukemia (1) · Leukemia, Lymphoid (1)
Biopsy (1) · Electrocardiography (1) · Hyperbaric Oxygenation (1) · Positron-Emission Tomography (1) · Rituximab (1) · Tomography, X-Ray Computed (1) · atezolizumab (1) · copanlisib (1)
National Cancer Institute (NCI) (1) · Stichting Hemato-Oncologie voor Volwassenen Nederland (1) · University Medical Center Groningen (1) · University of Rochester (1)
Netherlands (2) · United States (2) · Belgium (1)
M. Nijland, PhD/MD (1) · Omar Aljitawi (1) · Rahul Lakhotia, M.B.B.S. (1)
2017 (1)